Literature DB >> 28109354

Ureaplasma Transmitted From Donor Lungs Is Pathogenic After Lung Transplantation.

Ramiro Fernandez1, Amy Ratliff2, Donna Crabb2, Ken B Waites2, Ankit Bharat3.   

Abstract

Hyperammonemia is a highly fatal syndrome in lung recipients that is usually refractory to medical therapy. We recently reported that infection by a Mollicute, Ureaplasma, is causative for hyperammonemia and can be successfully treated with antimicrobial agents. However, it remains unknown whether the pathogenic strain of Ureaplasma is donor or recipient derived. Here we provide evidence that donor-derived Ureaplasma infection can be pathogenic. As such, we uncover a previously unknown lethal donor-derived opportunistic infection in lung recipients. Given the high mortality associated with hyperammonemia, strategies for routine donor screening or prophylaxis should be further evaluated in prospective studies.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28109354     DOI: 10.1016/j.athoracsur.2016.09.026

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Impact of Screening and Treatment of Ureaplasma species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience.

Authors:  Scott C Roberts; Ankit Bharat; Chitaru Kurihara; Rade Tomic; Michael G Ison
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

Review 2.  Hyperammonemia in lung transplant patients and its management: a review.

Authors:  Akshay Kumar; Shailesh Advani; Kichloo Asim; Mohamed A Mohamed; Farah Wani; Jagmeet Singh; Michael Albosta; Nimisha Shiwalkar; Suresh Keshavamurthy
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-03-14

Review 3.  Hyperammonemia syndrome in immunosuppressed individuals.

Authors:  Scott C Roberts; Waleed Malik; Michael G Ison
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

Review 4.  An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients.

Authors:  O C Smibert; M A Paraskeva; G Westall; Greg Snell
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

5.  A case of oropharyngeal Ureaplasma urealyticum infection in a human immunodeficiency virus positive bisexual male co-infected with human papilloma virus and Treponema pallidum.

Authors:  Nazneen Arif Suri; Sujeesh Sebastian; Deepika Yadav; Neena Khanna; Benu Dhawan
Journal:  JMM Case Rep       Date:  2018-01-10

6.  Novel insights into neuroinflammation: bacterial lipopolysaccharide, tumor necrosis factor α, and Ureaplasma species differentially modulate atypical chemokine receptor 3 responses in human brain microvascular endothelial cells.

Authors:  Christine Silwedel; Christian P Speer; Axel Haarmann; Markus Fehrholz; Heike Claus; Mathias Buttmann; Kirsten Glaser
Journal:  J Neuroinflammation       Date:  2018-05-23       Impact factor: 8.322

7.  Hyperammonemia by Ureaplasma urealyticum Pneumonia after Lung Transplantation.

Authors:  Maria Paparoupa; Markus Johannes Barten; Jocelyn de Heer; Hanna Sophie Giessen; Daniel Frings; Stefan Kluge
Journal:  Respir Med Case Rep       Date:  2020-05-06

8.  A novel bioreactor for the stable growth of Ureaplasma parvum and Ureaplasma urealyticum.

Authors:  Derek Fleming; Melissa Karau; Robin Patel
Journal:  J Microbiol Methods       Date:  2020-12-30       Impact factor: 2.363

9.  Case Report: About a Case of Hyperammonemia Syndrome Following Lung Transplantation: Could Metagenomic Next-Generation Sequencing Improve the Clinical Management?

Authors:  Charlotte Michel; Michela Raimo; Vladimir Lazarevic; Nadia Gaïa; Nina Leduc; Christiane Knoop; Marie Hallin; Olivier Vandenberg; Jacques Schrenzel; David Grimaldi; Maya Hites
Journal:  Front Med (Lausanne)       Date:  2021-07-06

Review 10.  Recent advances in understanding and managing infectious diseases in solid organ transplant recipients.

Authors:  Claire Aguilar; Shahid Husain; Olivier Lortholary
Journal:  F1000Res       Date:  2018-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.